|
PDIK1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.19659999972843E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.12520000003802E-06 |
| Normal-vs-Stage2 |
1.178130E-03 |
| Normal-vs-Stage3 |
1.06079999995234E-06 |
| Normal-vs-Stage4 |
7.15700000042396E-07 |
| Stage1-vs-Stage2 |
9.900400E-01 |
| Stage1-vs-Stage3 |
1.918810E-01 |
| Stage1-vs-Stage4 |
5.178200E-03 |
| Stage2-vs-Stage3 |
2.586800E-01 |
| Stage2-vs-Stage4 |
7.021900E-02 |
| Stage3-vs-Stage4 |
3.261400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.21719999968128E-07 |
| Normal-vs-AfricanAmerican |
5.817000E-04 |
| Normal-vs-Asian |
1.516520E-03 |
| Caucasian-vs-AfricanAmerican |
2.107400E-01 |
| Caucasian-vs-Asian |
6.813200E-01 |
| AfricanAmerican-vs-Asian |
4.325200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.4156000000275E-07 |
| Normal-vs-Female |
8.175400E-03 |
| Male-vs-Female |
2.002000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.53010000000431E-05 |
| Normal-vs-Extreme_Weight |
2.52510000020578E-07 |
| Normal-vs-Obese |
1.83019999999701E-05 |
| Normal-vs-Extreme_Obese |
4.837900E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.848800E-01 |
| Normal_Weight-vs-Obese |
7.560400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.762200E-01 |
| Extreme_Weight-vs-Obese |
3.862600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.444800E-01 |
| Obese-vs-Extreme_Obese |
8.265600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.260900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.56332999999842E-05 |
| Normal-vs-Age(61-80Yrs) |
1.8849000005261E-07 |
| Normal-vs-Age(81-100Yrs) |
3.74040000000742E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.464800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.323400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.100380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.559000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.317400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.115000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.36609999995741E-06 |
| Normal-VS-Type2 PRCC |
6.30319999528339E-08 |
| Normal-VS-KIRP CIMP |
4.222500E-04 |
| Normal-VS-Unclassified PRCC |
4.562600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.523800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.921200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.927000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.203400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.422100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.025200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.02669994728188E-09 |
| Normal-vs-N1 |
1.5762099999983E-05 |
| Normal-vs-N2 |
3.62889999999672E-05 |
| N0-vs-N1 |
4.808000E-01 |
| N0-vs-N2 |
5.454500E-02 |
| N1-vs-N2 |
4.556000E-02 |
|
|
